Response to "The efficacy of simvastatin is not influenced by CYP2D6 polymorphism" by Geisel et al
- PMID: 12732847
- DOI: 10.1016/s0009-9236(03)00054-7
Response to "The efficacy of simvastatin is not influenced by CYP2D6 polymorphism" by Geisel et al
Comment on
-
The efficacy of simvastatin is not influenced by CYP2D6 polymorphism.Clin Pharmacol Ther. 2002 Nov;72(5):595-6. Clin Pharmacol Ther. 2002. PMID: 12426523 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
